{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:15:22Z","timestamp":1783689322526,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identifying genetic cancer risk factors will lead to improved genetic counseling, cancer prevention and cancer care. Analyzing families with a strong history of breast cancer (BC) has been a successful method to identify genes that contribute to the disease. This has led to discoveries of high-risk genes like the BRCA-genes. Nevertheless, many BC incidences are of unknown causes. In this study, exome sequencing on 59 BC patients from 24 Swedish families with a strong history of BC was performed to identify variants in known and novel BC predisposing genes. First, we screened known BC genes and identified two pathogenic variants in the <jats:italic>BRIP1<\/jats:italic> and <jats:italic>PALB2<\/jats:italic> genes. Secondly, to identify novel BC genes, rare and high impact variants and segregating in families were analyzed to identify 544 variants in novel BC candidate genes. Of those, 22 variants were defined as high-risk variants. Several interesting genes, either previously linked with BC or in pathways that when flawed could contribute to BC, were among the detected genes. The strongest candidates identified are the <jats:italic>FANCM<\/jats:italic> gene, involved in DNA double-strand break repair, and the <jats:italic>RAD54L<\/jats:italic> gene, involved in DNA recombination. Our study shows identifying pathogenic variants is challenging despite a strong family history of BC. Several interesting candidates were observed here that need to be further studied.<\/jats:p>","DOI":"10.1038\/s41598-021-94316-z","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T10:03:18Z","timestamp":1626688998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sequencing for germline mutations in Swedish breast cancer families reveals novel breast cancer risk genes"],"prefix":"10.1038","volume":"11","author":[{"given":"Hafdis T.","family":"Helgadottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessada","family":"Thutkawkorapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lagerstedt-Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Lindblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"94316_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"94316_CR2","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1158\/1078-0432.CCR-08-1211","volume":"14","author":"OI Olopade","year":"2008","unstructured":"Olopade, O. I., Grushko, T. A., Nanda, R. & Huo, D. Advances in breast cancer: Pathways to personalized medicine. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 14, 7988\u20137999 (2008).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"94316_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/0284186X.2018.1529428","volume":"58","author":"C Wendt","year":"2019","unstructured":"Wendt, C. & Margolin, S. Identifying breast cancer susceptibility genes\u2014A review of the genetic background in familial breast cancer. Acta Oncol. Stockh. Swed. 58, 135\u2013146 (2019).","journal-title":"Acta Oncol. Stockh. Swed."},{"key":"94316_CR4","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.2270482","volume":"250","author":"JM Hall","year":"1990","unstructured":"Hall, J. M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684\u20131689 (1990).","journal-title":"Science"},{"key":"94316_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789\u2013792 (1995).","journal-title":"Nature"},{"key":"94316_CR6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/humu.23017","volume":"37","author":"MR Chandler","year":"2016","unstructured":"Chandler, M. R., Bilgili, E. P. & Merner, N. D. A review of whole-exome sequencing efforts toward hereditary breast cancer susceptibility gene discovery. Hum. Mutat. 37, 835\u2013846 (2016).","journal-title":"Hum. Mutat."},{"key":"94316_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1155\/2013\/747318","volume":"2013","author":"P Apostolou","year":"2013","unstructured":"Apostolou, P. & Fostira, F. Hereditary breast cancer: The era of new susceptibility genes. BioMed. Res. Int. 2013, 747 (2013).","journal-title":"BioMed. Res. Int."},{"key":"94316_CR8","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/ng.3785","volume":"49","author":"RL Milne","year":"2017","unstructured":"Milne, R. L. et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat. Genet. 49, 1767\u20131778 (2017).","journal-title":"Nat. Genet."},{"key":"94316_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05911","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","unstructured":"Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661\u2013678 (2007).","journal-title":"Nature"},{"key":"94316_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ng.3242","volume":"47","author":"K Michailidou","year":"2015","unstructured":"Michailidou, K. et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat. Genet. 47, 373\u2013380 (2015).","journal-title":"Nat. Genet."},{"key":"94316_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551, 92\u201394 (2017).","journal-title":"Nature"},{"key":"94316_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41588-020-0609-2","volume":"52","author":"kConFab Investigators","year":"2020","unstructured":"kConFab Investigators et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat. Genet. 52, 572\u2013581 (2020).","journal-title":"Nat. Genet."},{"key":"94316_CR13","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/nature05887","volume":"447","author":"DF Easton","year":"2007","unstructured":"Easton, D. F. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087\u20131093 (2007).","journal-title":"Nature"},{"key":"94316_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows\u2013Wheeler transform. Bioinformatics 26, 589\u2013595 (2010).","journal-title":"Bioinformatics"},{"key":"94316_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498 (2011).","journal-title":"Nat. Genet."},{"key":"94316_CR16","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164\u2013e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"94316_CR17","doi-asserted-by":"publisher","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","volume":"44","author":"NA O\u2019Leary","year":"2016","unstructured":"O\u2019Leary, N. A. et al. Reference sequence (RefSeq) database at NCBI: Current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 44, D733\u2013D745 (2016).","journal-title":"Nucleic Acids Res."},{"key":"94316_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry, S. T. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res. 29, 308\u2013311 (2001).","journal-title":"Nucleic Acids Res."},{"key":"94316_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"Exome Aggregation Consortium","year":"2016","unstructured":"Exome Aggregation Consortium et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"94316_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/ng.680","volume":"42","author":"Y Li","year":"2010","unstructured":"Li, Y. et al. Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat. Genet. 42, 969\u2013972 (2010).","journal-title":"Nat. Genet."},{"key":"94316_CR21","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ejhg.2017.130","volume":"25","author":"A Ameur","year":"2017","unstructured":"Ameur, A. et al. SweGen: A whole-genome data resource of genetic variability in a cross-section of the Swedish population. Eur. J. Hum. Genet. 25, 1253\u20131260 (2017).","journal-title":"Eur. J. Hum. Genet."},{"key":"94316_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"The 1000 Genomes Project Consortium","year":"2015","unstructured":"The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"94316_CR23","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/humu.23641","volume":"39","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. & Kattman, B. L. ClinVar at five years: Delivering on the promise. Hum. Mutat. 39, 1623\u20131630 (2018).","journal-title":"Hum. Mutat."},{"key":"94316_CR24","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: Improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"94316_CR25","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology. Genet. Med. Off. J. Am. Coll. Med. Genet. 17, 405\u2013424 (2015).","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"94316_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310\u2013315 (2014).","journal-title":"Nat. Genet."},{"key":"94316_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"94316_CR28","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ng.955","volume":"43","author":"T Rafnar","year":"2011","unstructured":"Rafnar, T. et al. Mutations in BRIP1 confer high risk of ovarian cancer. Nat. Genet. 43, 1104\u20131107 (2011).","journal-title":"Nat. Genet."},{"key":"94316_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou, A. C. et al. Breast-cancer risk in families with mutations in PALB2. N. Engl. J. Med. 371, 497\u2013506 (2014).","journal-title":"N. Engl. J. Med."},{"key":"94316_CR30","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1200\/JCO.2010.34.0778","volume":"29","author":"C Cybulski","year":"2011","unstructured":"Cybulski, C. et al. Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 29, 3747\u20133752 (2011).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"94316_CR31","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamaoncol.2016.5592","volume":"3","author":"G Neidhardt","year":"2017","unstructured":"Neidhardt, G. et al. Association between loss-of-function mutations within the FANCM gene and early-onset familial breast cancer. JAMA Oncol. 3, 1245\u20131248 (2017).","journal-title":"JAMA Oncol."},{"key":"94316_CR32","doi-asserted-by":"publisher","first-page":"15172","DOI":"10.1073\/pnas.1407909111","volume":"111","author":"JI Kiiski","year":"2014","unstructured":"Kiiski, J. I. et al. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc. Natl. Acad. Sci. U.S.A. 111, 15172\u201315177 (2014).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"94316_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41523-019-0127-5","volume":"5","author":"ABCTB Investigators","year":"2019","unstructured":"ABCTB Investigators et al. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. NPJ Breast Cancer 5, 38 (2019).","journal-title":"NPJ Breast Cancer"},{"key":"94316_CR34","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1038\/sj.onc.1202692","volume":"18","author":"M Matsuda","year":"1999","unstructured":"Matsuda, M. et al. Mutations in the RAD54 recombination gene in primary cancers. Oncogene 18, 3427\u20133430 (1999).","journal-title":"Oncogene"},{"key":"94316_CR35","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1093\/nar\/gkl481","volume":"34","author":"W-D Heyer","year":"2006","unstructured":"Heyer, W.-D., Li, X., Rolfsmeier, M. & Zhang, X.-P. Rad54: The Swiss Army knife of homologous recombination?. Nucleic Acids Res. 34, 4115\u20134125 (2006).","journal-title":"Nucleic Acids Res."},{"key":"94316_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20180568","volume":"38","author":"R Bansal","year":"2018","unstructured":"Bansal, R., Arya, V., Sethy, R., Rakesh, R. & Muthuswami, R. RecA-like domain 2 of DNA-dependent ATPase A domain, a SWI2\/SNF2 protein, mediates conformational integrity and ATP hydrolysis. Biosci. Rep. 38, 1\u201319 (2018).","journal-title":"Biosci. Rep."},{"key":"94316_CR37","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.3892\/mmr.2015.3565","volume":"12","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Identification of therapeutic targets for breast cancer using biological informatics methods. Mol. Med. Rep. 12, 1789\u20131795 (2015).","journal-title":"Mol. Med. Rep."},{"key":"94316_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s11658-018-0110-4","volume":"23","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Xu, H., Zhu, B., Qiu, Z. & Lin, Z. Systematic identification of the key candidate genes in breast cancer stroma. Cell. Mol. Biol. Lett. 23, 44 (2018).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"94316_CR39","first-page":"181","volume":"3","author":"G Minuti","year":"2015","unstructured":"Minuti, G. & Landi, L. MET deregulation in breast cancer. Ann. Transl. Med. 3, 181 (2015).","journal-title":"Ann. Transl. Med."},{"key":"94316_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13058-015-0547-6","volume":"17","author":"CM Ho-Yen","year":"2015","unstructured":"Ho-Yen, C. M., Jones, J. L. & Kermorgant, S. The clinical and functional significance of c-Met in breast cancer: A review. Breast Cancer Res. 17, 52 (2015).","journal-title":"Breast Cancer Res."},{"key":"94316_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10549-011-1946-8","volume":"134","author":"X Zhao","year":"2012","unstructured":"Zhao, X. et al. Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: A marker of poor prognosis in HER2\/neu-overexpressing breast cancer patients. Breast Cancer Res. Treat. 134, 171\u2013180 (2012).","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94316-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:44:50Z","timestamp":1670067890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94316-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94316"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94316-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"assertion":[{"value":"7 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14737"}}